Health Catalyst, Inc. HCAT
We take great care to ensure that the data presented and summarized in this overview for Health Catalyst, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding HCAT
View all-
First Light Asset Management, LLC Edina, MN13.4MShares$30.5 Million4.59% of portfolio
-
Black Rock Inc. New York, NY5.43MShares$12.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.3MShares$9.75 Million0.0% of portfolio
-
Whetstone Capital Advisors, LLC Shawnee Mission, KS3.73MShares$8.47 Million3.6% of portfolio
-
Impax Asset Management Group PLC2.75MShares$6.24 Million0.05% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.91MShares$4.34 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.74MShares$3.95 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.59MShares$3.61 Million0.0% of portfolio
-
Nepsis Inc.1.51MShares$3.43 Million1.67% of portfolio
-
Primecap Management CO Pasadena, CA1.37MShares$3.11 Million0.0% of portfolio
Latest Institutional Activity in HCAT
Top Purchases
Top Sells
About HCAT
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accuracy; population health management identifies improvement across the care continuum as well as actionable guidance for success and automated workflows; financial transformation providing costing and labor productivity insights and revenue capture; quality and safety improvement using clinical quality and patient safety data, analytics, and expert services; and national data ecosystem for thought leadership and mutual knowledge exchange to transform care delivery through next-gen insights. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah.
Insider Transactions at HCAT
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 01
2025
|
Benjamin Landry General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
14,387
-10.15%
|
$28,774
$2.9 P/Share
|
|
Dec 01
2025
|
Duncan Gallagher |
BUY
Grant, award, or other acquisition
|
Direct |
6,209
+4.75%
|
-
|
|
Dec 01
2025
|
Julie Larson Green |
BUY
Grant, award, or other acquisition
|
Direct |
5,731
+4.5%
|
-
|
|
Dec 01
2025
|
Daniel D. Burton Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
55,715
-3.85%
|
$111,430
$2.9 P/Share
|
|
Dec 01
2025
|
Jason Alger Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
20,619
-7.72%
|
$41,238
$2.9 P/Share
|
|
Dec 01
2025
|
Kevin Lee Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,401
-4.37%
|
$32,802
$2.9 P/Share
|
|
Dec 01
2025
|
Linda Llewelyn Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,762
-6.38%
|
$19,524
$2.9 P/Share
|
|
Sep 24
2025
|
Benjamin Albert President and COO |
BUY
Grant, award, or other acquisition
|
Direct |
467,000
+44.69%
|
-
|
|
Sep 05
2025
|
Benjamin Landry General Counsel |
SELL
Open market or private sale
|
Direct |
6,175
-4.17%
|
$18,525
$3.35 P/Share
|
|
Sep 02
2025
|
David Coy Ross Chief Tech & Product Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,360
-1.62%
|
$10,080
$3.36 P/Share
|
|
Sep 02
2025
|
Benjamin Landry General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,138
-2.08%
|
$9,414
$3.36 P/Share
|
|
Sep 02
2025
|
Linda Llewelyn Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,854
-1.83%
|
$8,562
$3.36 P/Share
|
|
Sep 02
2025
|
Daniel D. Burton Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,335
-0.57%
|
$25,005
$3.36 P/Share
|
|
Sep 02
2025
|
Daniel Le Sueur Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,663
-1.81%
|
$10,989
$3.36 P/Share
|
|
Sep 02
2025
|
Jason Alger Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,613
-0.97%
|
$7,839
$3.36 P/Share
|
|
Sep 02
2025
|
Kevin Lee Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,578
-1.21%
|
$13,734
$3.36 P/Share
|
|
Sep 01
2025
|
Duncan Gallagher |
BUY
Grant, award, or other acquisition
|
Direct |
4,970
+4.03%
|
-
|
|
Sep 01
2025
|
Julie Larson Green |
BUY
Grant, award, or other acquisition
|
Direct |
4,588
+3.81%
|
-
|
|
Sep 01
2025
|
Justin Spencer |
BUY
Grant, award, or other acquisition
|
Direct |
68,572
+50.0%
|
-
|
|
Jul 09
2025
|
S. Dawn Smith |
BUY
Grant, award, or other acquisition
|
Direct |
36,231
+26.27%
|
-
|
Last 12 Months Summary
| Grant, award, or other acquisition | 1.82M shares |
|---|
| Payment of exercise price or tax liability | 249K shares |
|---|---|
| Open market or private sale | 94.6K shares |